Europe must come together to confront omicron

TY - JOUR

T1 - Europe must come together to confront omicron

AU - Valdez, André Calero

AU - Iftekhar, Emil N.

AU - Oliu-Barton, Miquel

AU - Böhm, Robert

AU - Cuschieri, Sarah

AU - Czypionka, Thomas

AU - Dumpis, Uga

AU - Giordano, Giulia

AU - Hanson, Claudia

AU - Hel, Zdenek

AU - Helova, Anna

AU - Kickbusch, Ilona

AU - Klimek, Peter

AU - Kojan, Lilian

AU - Kretzschmar, Mirjam

AU - Krueger, Tyll

AU - Krutzinna, Jenny

AU - Lange, Berit

AU - Lazarus, Jeffrey V.

AU - Machado, Helena

AU - McKee, Martin

AU - Nagel, Kai

AU - Perc, Matja

AU - Petelos, Elena

AU - Popivanov, Nedyu

AU - Pradelski, Bary

AU - Prainsack, Barbara

AU - Schroeder, Kay

AU - Tsiodras, Sotirios

AU - Wilmes, Paul

AU - Wolff, Guntram

N1 - Funding Information: Competing interests: ZH received grants from the National Institutes of Health. JVL has received funding from AbbVie, Gilead Sciences, MSD, Intercept, Janssen, NovoVax, has participated in a board for the study ‘Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs (The QuickStart Study): a cluster randomised control trial - Australia’, and he is Vice-Chair of the EASL International Liver Foundation, all of which is unrelated to this work. MMK has received funding from the EU Horizon Europe, Wellcome Trust, and UKRI, and is part of Independent SAGE (UK) which is non-remunerated. KN has received funding from the TU Berlin and the BMBF (German Federal Ministry of Education and Research). BPrainsack is a member of the Austrian National Bioethics Committee advising the Federal Government, and in other COVID-19 related advisory positions, all of which are not remunerated. PW has received funding from the Luxembourg National Research Fund and the University of Luxembourg, is co-speaker of the Research Luxembourg COVID-19 Task Force and president of the Luxembourg Society for Microbiology. All other authors have no competing interests. Funding Information: Funding: Digital Society research program funded by the Ministry of Culture and Science of the German State of North Rhine-Westphalia (ACV). The Max Planck Society (ENI). German Research Foundation (DFG) grant BO 4466/2-1 (RB). University of Malta (SC). European Union’s Horizon 2020 research and innovation programme under grant agreement No 101016233 (PERISCOPE) (TC). National Research Programme project VPP-COVID-2020/1-0008 (UD). Strategic Grant MOSES at the University of Trento (GG). National Institutes of Health, USA (ZH). European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme, grant agreement no. 724460 (JK). European Union’s Horizon 2020 research and innovation program under grant agreement No 101003480 Project CORESMA (BL). Initiative and Networking Fund of the Helmholtz Association (BL). German Federal Ministry of Education and Research, NaFOUniMedCovid19 FKZ: 01KX2021 (BL). Netherlands Organisation for Health Research and Development (ZonMw), 91216062 (MK). European Union’s Horizon 2020 research and innovation program under grant agreement No 101003480 (Project CORESMA) (MK). University Paris-Dauphine and Bruegel (MOB). Slovenian Research Agency, Grant Nos. P1-0403 and J1-2457 (MP). University of Crete and from Maastricht University (EP). Bulgarian NSF under Grant Nº КП-06-ПН52/4 (NP). Luxembourg National Research Fund (FNR) as part of the COVID-19 Fast-Track research project CO-INFECTOMICS, COVID-19/2020-1/14729513 (PW). European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme, grant agreement no. 863664 (PW).

PY - 2022/1/12

Y1 - 2022/1/12

UR - http://www.scopus.com/inward/record.url?scp=85149803774&partnerID=8YFLogxK

U2 - 10.1136/bmj.o90

DO - 10.1136/bmj.o90

M3 - Editorial

C2 - 35027352

AN - SCOPUS:85149803774

SN - 0959-8146

VL - 376

JO - BMJ

JF - BMJ

M1 - 090

ER -